West Pharmaceutical Services | WST

Stock Price
250.73
Daily Change
3.19 1.29%
Monthly
5.67%
Yearly
-15.66%
Q3 Forecast
248.65

Peers Price Chg Day Year Date
Terumo 2,645.50 20.00 0.76% -0.02% Sep/05
Align Technology 139.12 4.42 3.28% -37.08% Sep/05
Avanos Medical 12.72 0.06 0.47% -46.37% Sep/05
Baxter International 24.42 0.84 3.56% -37.34% Sep/05
Becton, Dickinson and Co. 192.39 1.13 0.59% -17.28% Sep/05
Cooper Companies 68.09 0.09 0.13% -36.13% Sep/05
Charles River Laboratories 163.99 1.68 1.04% -12.63% Sep/05
Haemonetics 54.38 0.30 0.55% -25.75% Sep/05
Integra LifeSciences 15.99 0.34 2.17% -13.57% Sep/05
ICU Medical 131.24 5.61 4.47% -19.15% Sep/05
IQVIA Holdings 187.68 3.60 1.96% -22.83% Sep/05
J&J 178.43 -0.33 -0.18% 8.51% Sep/05
Medtronic 92.93 0.13 0.14% 3.32% Sep/05
Merit Medical Systems 92.97 0.82 0.89% -3.74% Sep/05
Neogen 5.75 0.01 0.17% -62.71% Sep/05
Insulet 348.43 1.96 0.57% 62.25% Sep/05
Quidel 28.68 0.89 3.20% -33.99% Sep/05
Repligen 124.56 3.98 3.30% -15.31% Sep/05
Solventum Corp 72.72 0.34 0.47% 9.85% Sep/05
STAAR Surgical 27.94 0.16 0.58% -10.22% Sep/05
West Pharmaceutical Services 250.73 3.19 1.29% -15.66% Sep/05
Dentsply International 14.62 0.29 2.02% -42.75% Sep/05

Indexes Price Day Year Date
US2000 2391 11.44 0.48% 14.33% Sep/05
US500 6481 -20.59 -0.32% 19.84% Sep/05

West Pharmaceutical Services traded at $250.73 this Friday September 5th, increasing $3.19 or 1.29 percent since the previous trading session. Looking back, over the last four weeks, West Pharmaceutical Services gained 5.67 percent. Over the last 12 months, its price fell by 15.66 percent. Looking ahead, we forecast West Pharmaceutical Services to be priced at 248.65 by the end of this quarter and at 242.51 in one year, according to Trading Economics global macro models projections and analysts expectations.

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.